Infections Herpes Simplex Virus Infection

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Herpes Simplex Virus Infection Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Herpes Simplex Virus Infection Projects
--BioAlliance Pharma
--Flamel Technologies SA ADS
--GlaxoSmithKline plc
--Medivir AB
--Mylan, Inc.
--NanoBio Corporation
--Redox Pharmaceutical Corporation
--Royalmount Pharma Inc.
--Teva Pharmaceutical Industries Ltd
--Transport Pharmaceuticals, Inc.

--Top Companies in early stage Herpes Simplex Virus Infection Projects
--ADVENTRX Pharmaceuticals Inc
--Acambis plc
--Avantogen Limited
--erly Australian Cancer Technology Limited)
--Antigenics Inc
--CEL-SCI Corporation
--BioVex Inc
--Cytogenix Inc
--Clavis Pharma ASA
--Novavax Inc
--Emisphere Technologies Inc
--Redox Pharmaceutical Corporation
--Pfizer Inc
--SkyePharma Plc
--Sinclair Pharma plc
--Symbigene
--Starpharma Holdings Ltd

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View